• Register
  • Login
  • Subscribe
  • Contact Us

Development of an Inhibitor for a New Therapeutic Target (Hit to Lead)

FranceTenders notice for Development of an Inhibitor for a New Therapeutic Target (Hit to Lead). The reference ID of the tender is 122240614 and it is closing on 09 Jul 2025.

Tender Details

  • Country: France
  • Summary: Development of an Inhibitor for a New Therapeutic Target (Hit to Lead)
  • FRT Ref No: 122240614
  • Deadline: 09 Jul 2025
  • Financier: Self Financed
  • Purchaser Ownership: Government
  • Tender Value: Refer Document
  • Notice Type: Tender
  • Document Ref. No.: 441287-2025
  • Purchaser's Detail:
    Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
  • Description:
  • We seek to develop an inhibitor against a newly identified therapeutic target in our laboratory.
    Our focus will be on a chemical series derived from HTS screening, which has subsequently
    been optimized during a hit expansion phase. This request for proposal (RFP) concerns a hitto-lead optimization phase, which is expected to last for six months. The Goal is to strengthen
    The structure-activity relationship (SAR) of Our Chemical Series.
    Molecular modeling and medicinal chemistry
    WP1. Design of computer assisted drugs (CADD)
    Wp2. Medicinal chemistry
    In vitro characterization and in cellulo
    Evaluation of in vitro activity
    First (tier one) and second level (tier Two) tests.
    Target commitment
    Cellular dosage of anticancer activity
    Doc Title: Development of an inhibitor for a new therapeutic target (Hit to Lead)
    Type contract: services
  • Documents:

 Tender Notice

If you are registered member, kindly login to view full details of this tender notice:

CLICK HERE TO LOGIN

Development of an Inhibitor for a New Therapeutic Target (Hit to Lead) - France Tender

The CURIE INSTITUTE, a Government sector organization in France, has announced a new tender for Development of an Inhibitor for a New Therapeutic Target (Hit to Lead). This tender is published on FranceTenders under FRT Ref No: 122240614 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-07-09.

The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.

FranceTenders Features

FranceTenders Features

Fresh and verified Tenders from France. Find, search and filter Tenders/Call for bids/RFIs/RFPs/RFQs/Auctions published by the government, public sector undertakings (PSUs) and private entities.

  • 1,000+ Tenders
  • Verified Tenders Only
  • New Tenders Every Day
  • Tenders Result Data
  • Archive & Historical Tenders Access
  • Consultants for RFI/RFP/RFQ
  • Tender Notifications & Alerts
  • Search, Sort, and Filter Tenders
  • Bidding Assistance & Consulting
  • Customer Support
  • Publish your Tenders
  • Export data to Excel
  • API for Tender Data
  • Tender Documents
Tender Experts

Get A Call From Tender Experts

Fill out the form below and you will receive a call from us within 24 hours.

Thank You for Contacting FranceTenders !!
Email Id is already exist !!
Captcha Image
Invalid Captcha !

Get FREE SAMPLE TENDERS from France in your email inbox.

  Chat with us